Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Arantza Farina-Sarasqueta"'
Autor:
Bárbara Andrade Barbosa, Saskia D. van Asten, Ji Won Oh, Arantza Farina-Sarasqueta, Joanne Verheij, Frederike Dijk, Hanneke W. M. van Laarhoven, Bauke Ylstra, Juan J. Garcia Vallejo, Mark A. van de Wiel, Yongsoo Kim
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Deconvolution methods reveal individual cell types in complex tissues profiled by bulk methods. Here the authors present a Bayesian deconvolution method that outperforms existing methods when benchmarked on >700 datasets, especially in estimating cel
Externí odkaz:
https://doaj.org/article/ab00233eafcc4cf68cdbf4b21d5d6744
Autor:
Jitske van den Bulk, Els M. E. Verdegaal, Dina Ruano, Marieke E. Ijsselsteijn, Marten Visser, Ruud van der Breggen, Thomas Duhen, Manon van der Ploeg, Natasja L. de Vries, Jan Oosting, Koen C. M. J. Peeters, Andrew D. Weinberg, Arantza Farina-Sarasqueta, Sjoerd H. van der Burg, Noel F. C. C. de Miranda
Publikováno v:
Genome Medicine, Vol 11, Iss 1, Pp 1-15 (2019)
Abstract Background The efficacy of checkpoint blockade immunotherapies in colorectal cancer is currently restricted to a minority of patients diagnosed with mismatch repair-deficient tumors having high mutation burden. However, this observation does
Externí odkaz:
https://doaj.org/article/1053242894a246058058f9231a19524f
Autor:
Babs G. Sibinga Mulder, Marjory Koller, Evelien W. Duiker, Arantza Farina Sarasqueta, Jakobus Burggraaf, Vincent E. de Meijer, Alexander L. Vahrmeijer, Frederik J.H. Hoogwater, Bert A. Bonsing, Gooitzen M. van Dam, J. Sven D. Mieog, Bobby K. Pranger
Publikováno v:
J Nucl Med
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 64(1), 82-89. SOC NUCLEAR MEDICINE INC
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 64(1), 82-89. SOC NUCLEAR MEDICINE INC
Rationale: Tumor visualization with near-infrared fluorescence (NIRF) imaging could aid exploration and resection of pancreatic cancer by visualizing the tumor in real time. Conjugation of the near-infrared fluorophore IRDye800CW to the monoclonal an
Autor:
Daan Linders, Marion Deken, Maxime van der Valk, Willemieke Tummers, Shadhvi Bhairosingh, Dennis Schaap, Gesina van Lijnschoten, Elham Zonoobi, Peter Kuppen, Cornelis van de Velde, Alexander Vahrmeijer, Arantza Farina Sarasqueta, Cornelis Sier, Denise Hilling
Publikováno v:
Diagnostics, Vol 11, Iss 3, p 516 (2021)
Rectal cancer patients with a complete response after neoadjuvant therapy can be monitored with a watch-and-wait strategy. However, regrowth rates indicate that identification of patients with a pathological complete response (pCR) remains challengin
Externí odkaz:
https://doaj.org/article/11186ba4a95444b6aedc789f8d7454ad
Autor:
Friso B. Achterberg, Babs G. Sibinga Mulder, Quisette P. Janssen, Bas Groot Koerkamp, Lieke Hol, Rutger Quispel, Bert A. Bonsing, Alexander L. Vahrmeijer, Casper H. J. van Eijck, Daphne Roos, Lars E. Perk, Erwin van der Harst, Peter-Paul L. O. Coene, Michail Doukas, Frank M. M. Smedts, Mike Kliffen, Marie-Louise F. van Velthuysen, Valeska Terpstra, Arantza Farina Sarasqueta, Hans Morreau, J. Sven D. Mieog
Publikováno v:
PLoS ONE, 18(1):e0280939. Public Library of Science
PLoS ONE, 18(1 January):e0280939
PLoS ONE, 18(1 January):e0280939
Background The diagnostic process of patients with suspect pancreatic lesions is often lengthy and prone to repeated diagnostic procedures due to inconclusive results. Targeted Next-Generation Sequencing (NGS) performed on cytological material obtain
Autor:
Martin N. J. M. Wasser, Mark C. Burgmans, Arantza Farina Sarasqueta, F. J. Sherida H. Woei-A-Jin, N.I. Weijl, Susanne Osanto, J Tom van Wezel, Minneke J. Coenraad, Jacobus Burggraaf
Publikováno v:
The Oncologist
Oncologist
The Oncologist, 26(10), 854-864. WILEY
oncologist, 26(10), 854-864. AlphaMed Press
Oncologist
The Oncologist, 26(10), 854-864. WILEY
oncologist, 26(10), 854-864. AlphaMed Press
Background Hepatocellular carcinoma (HCC) recurrence rates following locoregional treatment are high. As multireceptor tyrosine kinase inhibitors targeting vascular endothelial growth factor receptors (VEGFRs) are effective in advanced HCC, we assess
Autor:
Simone Augustinus, Pascale J.M. Schafrat, Boris V. Janssen, Bert A. Bonsing, Lodewijk A.A. Brosens, Olivier R.C. Busch, Stijn L.P. Crobach, Michael Doukas, Casper H. van Eijck, Lydia G.M. van der Geest, Bas Groot Koerkamp, Ignace H.J.T. de Hingh, Mihaela Raicu, Hjalmar C. van Santvoort, Marie-Louise F. van Velthuysen, Joanne Verheij, Arantza Farina Sarasqueta, Marc G. Besselink
Publikováno v:
European Journal of Surgical Oncology. 49:e31
Autor:
Manon, Suerink, Gül, Kilinç, Diantha, Terlouw, Hristina, Hristova, Lily, Sensuk, Demi, van Egmond, Arantza, Farina Sarasqueta, Alexandra M J, Langers, Tom, van Wezel, Hans, Morreau, Maartje, Nielsen, Amphia Ziekenhuis, Breda
Publikováno v:
Journal of Clinical Pathology, 74(11), 724-729. BMJ PUBLISHING GROUP
Journal of Clinical Pathology
Journal of clinical pathology, 74(11):207040, 724-729. BMJ Publishing Group
Journal of Clinical Pathology
Journal of clinical pathology, 74(11):207040, 724-729. BMJ Publishing Group
AimsPrevious estimates of the prevalence of mismatch repair (MMR) deficiency and Lynch syndrome in small bowel cancer have varied widely. The aim of this study was to establish the prevalence of MMR deficiency and Lynch syndrome in a large group of s
Autor:
Nik Dekkers, B Desschans, Jeroen Maljaars, Ron Wolterbeek, Severine Vermeire, Wim Laleman, Bart van Hoek, Menso Westerouen van Meeteren, Akin Inderson, Arantza Farina Sarasqueta, Kerem Sebib Korkmaz
Publikováno v:
Digestive and Liver Disease, 52, 528-533
Digestive and Liver Disease, 52, 5, pp. 528-533
Digestive and liver disease, 52(5), 528-533. Elsevier
Digestive and Liver Disease, 52, 5, pp. 528-533
Digestive and liver disease, 52(5), 528-533. Elsevier
Contains fulltext : 220062.pdf (Publisher’s version ) (Closed access) BACKGROUND: Liver transplantation remains the only effective evidence based treatment for advanced primary sclerosing cholangitis. However, recurrence of disease occurs in approx
Autor:
Marieke E. Ijsselsteijn, Els M. E. Verdegaal, Noel F C C de Miranda, Arantza Farina-Sarasqueta, Ruud van der Breggen, Dina Ruano, Andrew D. Weinberg, Natasja L. de Vries, Jitske van den Bulk, Sjoerd H. van der Burg, Jan Oosting, Koen C. M. J. Peeters, Marten Visser, Thomas Duhen, Manon van der Ploeg
Publikováno v:
Genome Medicine, Vol 11, Iss 1, Pp 1-15 (2019)
Genome Medicine
Genome Medicine
Background The efficacy of checkpoint blockade immunotherapies in colorectal cancer is currently restricted to a minority of patients diagnosed with mismatch repair-deficient tumors having high mutation burden. However, this observation does not excl